Brief: Geovax Announces Positive Interim Data Review For Phase 2 Clinical Trial Of Covid-19 Vaccine Booster In Patients With Chronic Lymphocytic Leukemia
19/11/2024 14:29
Nov 19 (Reuters) - GeoVax Labs Inc GOVX.O :
* GEOVAX ANNOUNCES POSITIVE INTERIM DATA REVIEW FOR PHASE 2
CLINICAL TRIAL OF COVID-19 VACCINE BOOSTER IN PATIENTS WITH
CHRONIC LYMPHOCYTIC LEUKEMIA
* GEOVAX LABS INC - DSMB RECOMMENDS CONTINUATION OF
GEO-CM04S1
VACCINE TRIAL
Source text: ID:nGNX4Cn7qY
Further company coverage: GOVX.O
((Reuters.Briefs@thomsonreuters.com;))